Advancing global health requires innovative solutions to some of the world’s most persistent challenges — and infectious diseases remain at the forefront. Our Collection, “Application of Nanomedicines in the Treatment of Infectious Diseases” directly supports the mission of UN Sustainable Development Goal 3 (SDG 3): Good Health and Well‑Being, which aims to ensure healthy lives and promote well‑being for all.

How this Collection contributes to SDG 3

Nanomedicine offers transformative potential in preventing, diagnosing, and treating infectious diseases. The research featured in this Collection aligns with SDG 3 by:

• Improving access to effective therapies through targeted drug delivery systems that enhance treatment precision and reduce side effects.
• Supporting the fight against global infectious threats, including antimicrobial resistance, viral infections, and emerging pathogens.
• Enabling earlier and more accurate diagnosis with nanoscale sensors and imaging tools.
• Accelerating innovation in vaccines and immunotherapies, contributing to stronger global health resilience.

Why this matters

Infectious diseases continue to cause significant morbidity and mortality worldwide. By advancing nanotechnology‑enabled solutions, this Collection highlights research that can strengthen healthcare systems, reduce disease burden, and bring us closer to achieving SDG 3 targets.

Explore the Collection

https://link.springer.com/collections/eaceifdgch

We welcome researchers, clinicians, and innovators to explore the cutting‑edge work featured here and join the global effort to build a healthier, more resilient future. If you have questions, ideas, or would like to contribute, get in touch with the  me at vivian.bai@springernature.com.